Paragonix Technologies SherpaPak Improves 1-Year Survival in Heart Transplant Patients in Real-World Study
GUARDIAN Registry data presented at ISHLT 2022 has shown a 72% reduction (p=0.005) in Severe PGD (primary graft dysfunction) and a 39% reduction (p=0.03) in Mechanical Circulatory Support, in addition to improvement in 1-year survival
Source: dicardiology.com